SPARK THERAPEUTICS, INC.

Spark Therapeutics, Inc. specializes in the manufacturing of pharmaceutical preparations, with a focus on developing and producing specialized drugs, hematological agents, and related therapeutics for government healthcare systems. Their technical expertise lies in GMP-compliant pharmaceutical manufacturing processes, including formulation development, aseptic processing, and quality control systems aligned with FDA and VA regulatory standards. The company demonstrates deep competency in the end-to-end production of complex drug products, ensuring batch consistency, stability, and compliance with cGMP requirements essential for federal procurement. Their specialization in hematological and specialty pharmaceuticals positions them as a reliable supplier for mission-critical therapies requiring stringent manufacturing controls. The contractor has delivered pharmaceutical products to the Department of Veterans Affairs under a Federal Supply Schedule contract, indicating a proven ability to meet the VA’s requirements for reliable, scalable, and compliant drug supply chains. Their work supports veteran healthcare programs involving chronic disease management, immunotherapy, and blood disorder treatments, aligning with VA’s priorities for accessible, high-quality pharmaceuticals. Their primary industry focus is on NAICS 325412 — Pharmaceutical Preparation Manufacturing — which encompasses the production of finished dosage forms such as injectables, oral solids, and specialty formulations. The company operates within the niche of government-sourced specialty pharmaceuticals, serving clinical needs that demand high-purity, low-volume, or complex-manufactured products not typically addressed by mass-market producers. Spark Therapeutics, Inc. is a small business structured as a 2L entity, headquartered in Philadelphia, Pennsylvania. While no federal certifications are currently listed, their operational footprint is centered on federal pharmaceutical supply, with infrastructure designed to support government-grade quality assurance, traceability, and regulatory documentation. Their geographic presence and manufacturing capabilities position them as a targeted supplier within the federal healthcare supply chain.